Longitudinal Prediction of Ventricular Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy

被引:19
|
作者
Carrick, Richard T. [1 ]
te Riele, Anneline S. J. M. [2 ,3 ]
Gasperetti, Alessio [1 ,2 ]
Bosman, Laurens [2 ]
Muller, Steven A. [2 ]
Pendleton, Catherine [1 ]
Tichnell, Crystal [1 ]
Murray, Brittney [1 ]
Yap, Sing-Chien [3 ,4 ]
van den Berg, Maarten P. [5 ]
Wilde, Arthur [4 ,6 ]
Zeppenfeld, Katja [7 ]
Hays, Allison [1 ]
Zimmerman, Stefan L. [1 ]
Tandri, Harikrishna [1 ]
Cadrin-Tourigny, Julia [8 ]
van Tintelen, Peter [4 ,9 ]
Calkins, Hugh [1 ]
James, Cynthia A. [1 ]
Wu, Katherine C. [1 ]
机构
[1] Johns Hopkins Med Inst, Div Cardiol, Baltimore, MD 21287 USA
[2] Univ Med Ctr Utrecht, Dept Heart & Lungs, Div Cardiol, Utrecht, Netherlands
[3] Low Prevalence & Complex Dis Heart ERN Guard Hear, European Network Rare, Utrecht, Netherlands
[4] Univ Med Ctr Rotterdam, Rotterdam, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[6] Univ Amsterdam, Med Ctr, Heart Failure & Arrhythmias, Amsterdam Cardiovasc Sci, Amsterdam, Netherlands
[7] Leiden Univ, Heart Ctr Leiden, Leiden, Netherlands
[8] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada
[9] Univ Med Ctr Utrecht, Dept Clin Genet, Utrecht, Netherlands
基金
美国国家卫生研究院;
关键词
cardiomyopathy; death; sudden; cardiac; defibrillator; implantable; risk factors; tachycardia; SUDDEN-DEATH; ANTIARRHYTHMIC-DRUGS; TIME; ASSOCIATION; PROGRESSION; DIAGNOSIS; EFFICACY; THERAPY; DISEASE; EVENTS;
D O I
10.1161/CIRCEP.122.011207
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The arrhythmogenic right ventricular cardiomyopathy (ARVC) risk calculator stratifies risk for incident sustained ventricular arrhythmias (VA) at the time of ARVC diagnosis. However, included risk factors change over time, and how well the ARVC risk calculator performs at follow-up is unknown. METHODS: This was a retrospective analysis of patients with definite ARVC and without prior sustained VA. Risk factors for VA including age, nonsustained ventricular tachycardia, premature ventricular complex burden, T-wave inversions on electrocardiogram, cardiac syncope, right ventricular function, therapeutic medication use, and exercise intensity were assessed at the time of 2010 Task Force Criteria based ARVC diagnosis and upon repeat evaluations. Changes in these risk factors were analyzed over 5-year follow-up. The 5-year risk of VA was predicted longitudinally using (1) the baseline ARVC risk calculator prediction, (2) the ARVC risk prediction calculated using updated risk factors, and (3) time-varying Cox regression. Discrimination and calibration were assessed in comparison to observed VA event rates. RESULTS: Four hundred eight patients with ARVC experiencing 132 primary VA events were included. Matched comparison of risk factors at baseline versus at 5 years of follow-up revealed decreased burdens of premature ventricular complexes (-1200/day) and nonsustained ventricular tachycardia (-14%). Presence of significant right ventricular dysfunction and number of T-wave inversions on electrocardiogram were unchanged. Observed risk for VA decreased by 13% by 5 years follow-up. The baseline ARVC risk calculator's ability to predict 5-year VA risk worsened during follow-up (C statistics, 0.83 at diagnosis versus 0.68 at 5 years). Both the updated ARVC risk calculator (C statistics of 0.77) and time-varying Cox regression model (C statistics, 0.77) had strong discrimination. The updated ARVC risk calculator overestimated 5-year VA risk by an average of +6%. CONCLUSIONS: Risk factors for VA in ARVC are dynamic, and overall risk for incident sustained VA decreases during follow-up. Up-to-date risk factor assessment improves VA risk stratification. [GRAPHICS] .
引用
收藏
页码:728 / 739
页数:12
相关论文
共 50 条
  • [1] Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator
    Jorda, Paloma
    Bosman, Laurens P.
    Gasperetti, Alessio
    Mazzanti, Andrea
    Gourraud, Jean-Baptiste
    Davies, Brianna
    Frederiksen, Tanja Charlotte
    Moreno Weidmann, Zoraida
    Di Marco, Andrea
    Roberts, Jason D.
    MacIntyre, Ciorsti
    Seifer, Colette
    Deliniere, Antoine
    Alqarawi, Wael
    Kukavica, Deni
    Minois, Damien
    Trancuccio, Alessandro
    Arnaud, Marine
    Targetti, Mattia
    Martino, Annamaria
    Oliviero, Giada
    Pipilas, Daniel C.
    Carbucicchio, Corrado
    Compagnucci, Paolo
    Dello Russo, Antonio
    Olivotto, Iacopo
    Calo, Leonardo
    Lubitz, Steven A.
    Cutler, Michael J.
    Chevalier, Philippe
    Arbelo, Elena
    Giuliana Priori, Silvia
    Healey, Jeffrey S.
    Calkins, Hugh
    Casella, Michela
    Jensen, Henrik Kjaerulf
    Tondo, Claudio
    Tadros, Rafik
    James, Cynthia A.
    Krahn, Andrew D.
    Cadrin-Tourigny, Julia
    EUROPEAN HEART JOURNAL, 2022, 43 (32) : 3041 - 3052
  • [2] Management of arrhythmogenic right ventricular cardiomyopathy
    Silvano, Maria
    Mastella, Giulio
    Zorzi, Alessandro
    Migliore, Federico
    Pilichou, Kalliopi
    Bauce, Barbara
    Rigato, Ilaria
    Perazzolo Marra, Martina
    Iliceto, Sabino
    Thiene, Gaetano
    Basso, Cristina
    Corrado, Domenico
    MINERVA MEDICA, 2016, 107 (04) : 194 - 216
  • [3] Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy
    Gasperetti, Alessio
    James, Cynthia A.
    Carrick, Richard T.
    Protonotarios, Alexandros
    te Riele, Anneline S. J. M.
    Cadrin-Tourigny, Julia
    Compagnucci, Paolo
    Duru, Firat
    van Tintelen, Peter
    Elliot, Perry M.
    Calkins, Hugh
    EUROPACE, 2023, 25 (11):
  • [4] Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy
    Calkins, Hugh
    Corrado, Domenico
    Marcus, Frank
    CIRCULATION, 2017, 136 (21) : 2068 - 2082
  • [5] Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy
    Wallace, Ryan
    Calkins, Hugh
    ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 2021, 10 (01) : 26 - 32
  • [6] Arrhythmogenic Right Ventricular Cardiomyopathy Clinical Course and Predictors of Arrhythmic Risk
    Mazzanti, Andrea
    Ng, Kevin
    Faragli, Alessandro
    Maragna, Riccardo
    Chiodaroli, Elena
    Orphanou, Nicoletta
    Monteforte, Nicola
    Memmi, Mirella
    Gambelli, Patrick
    Novelli, Valeria
    Bloise, Raffaella
    Catalano, Oronzo
    Moro, Guido
    Tibollo, Valentina
    Morini, Massimo
    Bellazzi, Riccardo
    Napolitano, Carlo
    Bagnardi, Vincenzo
    Priori, Silvia G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (23) : 2540 - 2550
  • [7] Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy
    Protonotarios, Alexandros
    Anastasakis, Aris
    Panagiotakos, Demosthenes B.
    Antoniades, Loizos
    Syrris, Petros
    Vouliotis, Apostolos
    Stefanadis, Christodoulos
    Tsatsopoulou, Adalena
    McKenna, William J.
    Protonotarios, Nikos
    EUROPACE, 2016, 18 (04): : 610 - 616
  • [8] Management of arrhythmogenic right ventricular cardiomyopathy
    Al-Aidarous, Sayed
    Protonotarios, Alexandros
    Elliott, Perry M.
    Lambiase, Pier D.
    HEART, 2024, 110 (03) : 156 - 162
  • [9] Arrhythmic outcome of arrhythmogenic right ventricular cardiomyopathy patients without implantable defibrillators
    Wang, Weijia
    Cadrin-Tourigny, Julia
    Bhonsale, Aditya
    Tichnell, Crystal
    Murray, Brittney
    Monfredi, Oliver
    Chrispin, Jonathan
    Crosson, Jane
    Tandri, Harikrishna
    James, Cynthia A.
    Calkins, Hugh
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2018, 29 (10) : 1396 - 1402
  • [10] Impact of Exercise Restriction on Arrhythmic Risk Among Patients With Arrhythmogenic Right Ventricular Cardiomyopathy
    Wang, Weijia
    Orgeron, Gabriela
    Tichnell, Crystal
    Murray, Brittney
    Crosson, Jane
    Monfredi, Oliver
    Cadrin-Tourigny, Julia
    Tandri, Harikrishna
    Calkins, Hugh
    James, Cynthia A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (12):